Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02743000 · ClinicalTrials.gov registry record
Food and the Brain
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 83
- Enrollment target
NCT02743000: Completed study, sponsored by Stanford University.
NCT02743000 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02743000 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
The proposed study will examine the role of reward and emotion in women with and without a history of binge eating. It is important to understand how the brain responds to reward and emotion in binge eating in order to identify different pathways toward binge eating and provide individualized targets for treatment. This is particularly important in light of the fact that for many patients, the current treatments for binge eating are not effective.
Primary Outcome
Functional magnetic resonance imaging will be used to measure brain activity at rest and connectivity between brain regions will be examined.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2016-01 |
| Est. Completion | 2020-04 |
What the finished NCT02743000 record still lists
NCT02743000 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02743000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02743000 about?
NCT02743000 is a clinical study titled "Food and the Brain". The proposed study will examine the role of reward and emotion in women with and without a history of binge eating. It is important to understand how the brain responds to reward and emotion in binge eating in order to identify different pathways toward binge eating and provide individualized target...
What is the current status of trial NCT02743000?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2016-01. Estimated completion is 2020-04.
Who is sponsoring clinical trial NCT02743000?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia